Kristian Larsen • 1951 • Stavanger • 12 roles • 7 shareholdings

This website uses cookies to enhance the user experience.

Roles

Management

Name	Role	Total operating income	Total equity	Shares
P POLYPHENOLS AS	Managing Director/CEO	5,563,756	6,535,323	3.45 % indirectly
B BIOSYNTH AS	Managing Director/CEO	1,776,566	1,865,189	3.45 % indirectly
D DIAGNOSTRIX AS	Managing Director/CEO	351,600	2,612,835	1.98 % indirectly
B BREEDSENSE AS	Managing Director/CEO	38,607	-3,404,586	1.76 % indirectly
M MEDPALETT AS	Managing Director/CEO	71,981,902	69,820,981	-

Boards

Name	Role	Total operating income	Total equity	Shares
P POLYPHENOLS AS	Board Member	5,563,756	6,535,323	3.45 % indirectly
B BIOLINK INDUSTRIAL AS	Board Member	2,998,314	5,203,763	3.45 % indirectly
B BIOLINK GROUP AS	Board Member	8,154,275	107,958,947	3.45 % directly
B BIOSYNTH AS	Board Member	1,776,566	1,865,189	3.45 % indirectly
D DIAGNOSTRIX AS	Board Member	351,600	2,612,835	1.98 % indirectly
B BREEDSENSE AS	Board Member	38,607	-3,404,586	1.76 % indirectly
M MEDPALETT AS	Chairman	71,981,902	69,820,981	-

Last update: Jun 28, 2025

Related industries4

Direct relationships5

SS
Sjur Svaboe1943
POLYPHENOLS AS, BIOLINK INDUSTRIAL AS, BIOLINK GROUP AS, BREEDSENSE AS, DIAGNOSTRIX AS, BIOSYNTH AS
KS
Kåre Svaboe1968
POLYPHENOLS AS, BIOLINK INDUSTRIAL AS, BIOLINK GROUP AS, BIOSYNTH AS
SO
Svein Ove Føyen1961
BIOLINK GROUP AS, BREEDSENSE AS, DIAGNOSTRIX AS
TB
Torleiv Bilstad1947
BIOLINK GROUP AS, BREEDSENSE AS, DIAGNOSTRIX AS
LK
Linn Kathrine Høiland Sagerup1981
BIOLINK INDUSTRIAL AS

Shares owned by Kristian Larsen

Name	Share class	Total operating income	Total equity	Share
B BIOLINK GROUP AS	NO0010067721	8,154,275	107,958,947	3.45 % directly
P POLYPHENOLS AS		5,563,756	6,535,323	3.45 % indirectly
B BIOLINK INDUSTRIAL AS		2,998,314	5,203,763	3.45 % indirectly
B BIOSYNTH AS		1,776,566	1,865,189	3.45 % indirectly
I IMUXOL AS		0	-1,261,217	3.45 % indirectly
D DIAGNOSTRIX AS		351,600	2,612,835	1.98 % indirectly
B BREEDSENSE AS		38,607	-3,404,586	1.76 % indirectly

Limited to direct ownership positions of 0.5% or more.

Last update: Jun 2, 2025